Discovery of a novel and potent KRAS<sup>G12V</sup>-targeting peptide with antiproliferative activity against colorectal cancer cells.

J Enzyme Inhib Med Chem · 2026 · PMC13262105 · PMID 42274165

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Differences with P < 0.001 were considered highly significant.

also in 132,142 other papers

showed a trendno p-value reported

This reduction showed a trend similar to that observed with the positive reference peptide H-REV107, but was more pronounced under the present experimental conditions.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Discovery of a novel and potent KRAS&lt;sup&gt;G12V&lt;/sup&gt;-targeting peptide with antiproliferative activity against colorectal cancer cells.

The sentences

Discovery of a novel and potent KRAS<sup>G12V</sup>-targeting peptide with antiproliferative activity against colorectal cancer cells.